According to the latest equity disclosure information from HKEX on June 24th, 2024, on June 18th, 2024, Remegen (09995.HK) was reduced by E Fund Management Co., Ltd. to 536,000 shares at an average price of HKD 26.5858 per share, involving approximately HKD 14.25 million.
After the shareholding reduction, the latest number of shares held by E Fund Management Co., Ltd. is 9.1615 million shares, and the shareholding ratio has decreased from 5.12% to 4.83%.